Current HDFN treatments effective in improving outcomes
Modern HDFN therapies are largely effective, but global treatment access is not uniform.
Modern HDFN therapies are largely effective, but global treatment access is not uniform.
Though a child’s HDFN diagnosis is in no way their parent’s fault, it is normal to have feelings of guilt after they are diagnosed.
Learn more about what you can expect if your child has to stay in a neonatal intensive care unit after birth.
Though drawing blood may be painful or stressful for an infant, there are ways parents can help the process be more comfortable.
Researchers reached a consensus on six recommendations regarding the management of alloimmunized pregnancies.
Learn more about the resources needed to treat HDFN and what to look for when choosing a hospital for your delivery and care.
A non-invasive fetal Rhesus D screening method could improve the care of pregnant women who may be at risk of HDFN.
A fetal loss of any kind, whether it be an abortion or a miscarriage, can cause a mother to become sensitized.
A shortage in RhIG supply has forced medical institutions to adapt to ensure that vulnerable patients continue to receive this treatment.
A pregnancy affected by HDFN due to rare antibodies was successfully managed, and the affected infant was born without serious complications.